Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5785897 | 0.99 | MEN1 (0.44) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL1830325 | 0.99 | MEN1 (0.44) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL7564008 | 0.88 | NPSR1 (0.40) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL7829858 | 0.88 | MAPT (0.48) | TP53TSHRALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL7556606 | 0.87 | MEN1 (0.43) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL7559771 | 0.87 | MEN1 (0.50) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL321543 | 0.87 | MEN1 (0.45) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL7750180 | 0.87 | MEN1 (0.45) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL2485564 | 0.86 | MEN1 (0.45) | MEN1KMT2ATP53TSHRALDH1A1 | |
| SCHEMBL7818937 | 0.85 | PTGS2 (0.44) | MEN1KMT2AALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010070449-A2 | HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2010-06-24 | — | — | WO | claimed |
| WO-2010001257-A2 | NOVEL SOLID STATE FORMS OF LAQUINIMOD AND ITS SODIUM SALT | ACTAVIS GROUP PTC EHF (IS) | 2010-01-07 | — | — | WO | claimed |
| EP-1511732-A1 | PROCESS FOR THE MANUFACTURE OF QUINOLINE DERIVATIVES | Active Biotech AB (SE) | 2005-03-09 | — | — | EP | claimed |
| WO-2003106424-A1 | PROCESS FOR THE MANUFACTURE OF QUINOLINE DERIVATIVES | ACTIVE BIOTECH AB (SE) | 2003-12-24 | — | — | WO | claimed |
| EP-2642855-A1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF QUINOLINE DERIVATIVES SUCH AS LAQUINIMOD SODIUM | Mapi Pharma Limited (IL) | 2013-10-02 | — | — | EP | disclosed |
| EP-2597954-A1 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2013-06-05 | — | — | EP | disclosed |
| EP-2590949-A1 | METHOD FOR MANUFACTURING OF QUINOLINE-3-CARBOXAMIDES | Active Biotech AB (SE) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012070051-A1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF QUINOLINE DERIVATIVES SUCH AS LAQUINIMOD SODIUM | MAPI PHARMA LTD. (IL) | 2012-05-31 | — | — | WO | disclosed |
| WO-2012004338-A1 | METHOD FOR MANUFACTURING OF QUINOLINE-3-CARBOXAMIDES | ACTIVE BIOTECH AB (SE) | 2012-01-12 | — | — | WO | disclosed |
| WO-2012006538-A1 | DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2012-01-12 | — | — | WO | disclosed |
| EP-2318371-A2 | NOVEL SOLID STATE FORMS OF LAQUINIMOD AND ITS SODIUM SALT | Actavis Group PTC EHF (IS) | 2011-05-11 | — | — | EP | disclosed |
| EP-2276740-A1 | IMPROVED PROCESS FOR PREPARING QUINOLINE-3-CARBOXAMIDE DERIVATIVES | Actavis Group PTC EHF (IS) | 2011-01-26 | — | — | EP | disclosed |
| WO-2010001257-A2 | NOVEL SOLID STATE FORMS OF LAQUINIMOD AND ITS SODIUM SALT | ACTAVIS GROUP PTC EHF (IS) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009133468-A1 | IMPROVED PROCESS FOR PREPARING QUINOLINE-3-CARBOXAMIDE DERIVATIVES | ACTAVIS GROUP PTC EHF (IS) | 2009-11-05 | — | — | WO | disclosed |
| EP-1720531-A2 | NEW COMPOSITIONS CONTAINING QUINOLINE COMPOUNDS | Active Biotech AB (SE) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005074899-A2 | NEW COMPOSITIONS CONTAINING QUINOLINE COMPOUNDS | ACTIVE BIOTECH AB (SE) | 2005-08-18 | — | — | WO | disclosed |
| EP-1073639-A1 | QUINOLINE DERIVATIVES | Active Biotech AB (SE) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999055678-A1 | QUINOLINE DERIVATIVES | ACTIVE BIOTECH AB (SE) | 1999-11-04 | — | — | WO | disclosed |